| Otsuka Pharmaceutical Co., Ltd. (OPC) is engaged in | | | | Scope |
| the development and distribution of pharmaceuticals | | | | - Provides key company information for business |
| and consumer products for the healthcare industry. | | | | intelligence needs |
| The company operates eight business segments | | | | - Gives information on the company's major recent |
| specializing in consumer products, diagnostic drugs, dry | | | | financial deals including Mergers and Acquisitions, asset |
| powder inhalation technology, diagnostics, international | | | | transactions, PE/VC deals, equity offerings, debt |
| sales, rejuvenation (cosmedics) sciences, opthalmology | | | | offerings and partnerships. |
| and dermatology, and pharmaceuticals. Its product | | | | - Data is supplemented with details on the company's |
| portfolio includes ethical drugs, diagnostics and medical | | | | history, key executives, business description, locations |
| equipments, skin care products, nutraceuticals and over | | | | and subsidiaries as well as a list of products and |
| the counter drugs. Its products are marketed through a | | | | services and the latest available company statement. |
| broad range of distributors worldwide. The company is | | | | Reasons to buy |
| headquartered in Tokyo, Japan | | | | - A quick "one-stop-shop" to understand the company. |
| Otsuka Pharmaceutical Co., Ltd. - Medical Equipment - | | | | - Support sales activities by understanding your |
| Deals and Alliances Profile is an essential source for | | | | customers' businesses. |
| company data and information. The profile examines | | | | - Qualify prospective partners and suppliers. |
| the company's key business structure and operations, | | | | - Understand and respond to your competitors' |
| history and products, and provides summary analysis | | | | business structure, strategy and prospects through. |
| of its key revenue lines and strategy as well as | | | | - Understanding the key deals which have shaped the |
| highlighting the company's major recent financial deals. | | | | company. |